THE AIM ORGANIZATION (AIM) LICENSED AS A PHARMACY

AIM Set to Deliver Point of Care(POC) Medication at Clinics

AIM announces Point of Care dispensing into its specialized treatments for patients suffering from osteoarthritis and spine-related diseases. Physician-led dispensing has demonstrated significant improvements in patient compliance, treatment outcomes, and practice revenue.

Ralph Lombardo, AIM’s Chief Executive Officer, expressed his enthusiasm about the implementation of licensed dispensing services in all of their clinics, “By providing necessary medications with convenient access, our focus is to enhance patient satisfaction and drive quality improvements. Point of Care dispensing has been adopted in Urology, Oncology, and other specialties. The American Medical Association supports Point of Care dispensing, and existing literature clearly highlights enhanced treatment outcomes, improved medication adherence, and significant increases in practice revenue.  Our AIM is to elevate the overall patient journey which is a key component of driving additional foot traffic.”

By adding this innovative feature, AIM Organization is positioning itself as a forward-thinking healthcare provider committed to enhancing patient experiences and medical outcomes. This move represents another step in the organization’s mission to leave a lasting, positive mark on the communities it serves.



About AIM
The AIM Organization is recognized for its commitment to delivering high-quality healthcare services. Its mission revolves around providing superior care and achieving improved outcomes through a combination of innovation and patient-centered approaches. AIM consistently makes a positive impact on the health communities it serves.

1.       Palacio ,A. Chen, J. Impact of a Physician-Led Point of Care Medication Delivery Systemon Medication Adherence. American Journal of Managed Care, 7-2018- Vol 22 Issue7.
2.       Moroshek,J. Improving outpatient primary medication adherence with physician guided, automated dispensing. Journal of ClinicoEconomics: National Institute of Health  2017; 9: 59–63.  2017 Jan 5. doi: 10.2147/CEOR.S114416
3.       Talley,B. Benefits of In-Office medication dispensing; Journal of Practice Management;January/February 2012.

For more information, please contact David Fann, Chief Investment Officer at: david.fann@theaimorganization.com
904.251.4910

send us a message

Got a QUESTION/MESSAGE?

Similar Posts